Today during trading, Eupraxia Pharmaceuticals Inc opened at $4.79 and closed at $3.87. It traded at a low of $3.85 to a high of $4.79.

Share prices eased -5.61% from the previous day's close of $4.10.

Today across North America, the TSX Composite closed -0.27% at 22051.79, the S&P 500 closed -1.23% at 5147.21, the Dow Jones Industrial Average closed -1.35% at 38596.98 and the Nasdaq Composite closed -1.40% at 16049.08.

Eupraxia Pharmaceuticals Inc traded under EPRX on the Toronto Stock Exchange (TSX).

Trading volume was 148,819 on 342 total trades, while having an average volume of 87,132 in the last five days.

The TSX overall saw 2,800 price advancers against 2,386 declines and 147 unchanged.

During the prior 52 weeks, EPRX.TO has traded as high as $9.10 (July 05,2023) and low as $3.85 (April 05,2024). Moreover, in the last 52 weeks, Eupraxia Pharmaceuticals Inc's shares have shrunken -9.79 percent, while this year, they have shrunken -27.93%.

Following today's trading, Eupraxia Pharmaceuticals Inc has a market capitalization of $146.05 million on a float of 35,623 shares outstanding. Its annual EPS is $-1.53.

Eupraxia Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Victoria, CAN.

Currently, Eupraxia Pharmaceuticals Inc has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..